Last checked at 4 Jun 2021 07:00
4 June 2021
Microsaic Systems plc
("Microsaic" or the "Company")
Pre-Annual General Meeting Q&A
Microsaic (AIM: MSYS), the developer of point of need mass spectrometry instruments, announces that Glenn Tracy, CEO, and Bevan Metcalf, FD, will host a short Q&A session on Friday 11 June 2021 at 10.00 a.m. BST via the Investor Meet Company platform. This session will provide shareholders with the opportunity to raise questions prior to the Company's Annual General Meeting being held at 10.00 a.m. BST on 17 June 2021 (the "AGM") and prior to the deadline for submitting proxy votes to the Company's registrar in respect of the AGM, which is by 10.00 a.m. BST on 15 June 2021. This session will replace the Q&A session planned to be held immediately after the AGM.
The pre-AGM Q&A session is open to all existing and potential shareholders. Questions can be submitted before the session via the Investor Meet Company dashboard up until 9.00 a.m. the day before the presentation or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet Microsaic Systems plc via:
https://www.investormeetcompany.com/microsaic-systems-plc/register-investor
Investors who already follow Microsaic Systems plc on the Investor Meet Company platform will automatically be invited.
Reminder re: Arrangements for AGM
Under normal circumstances, the Board values greatly the opportunity to meet shareholders in person. However, the Board considers the safety and wellbeing of both its shareholders and employees to be of paramount importance. With this in mind, and in light of the COVID-19 pandemic, the Chairman of the meeting and one other shareholder will attend the AGM thus fulfilling the requirement of the Company's Articles of Association for a quorum to be present consisting of two persons entitled to vote upon the business to be transacted, present in person or by proxy. Accordingly, on health and safety grounds other shareholders and proxies for shareholders will not be permitted to attend the AGM and shareholders are urged to submit the Form of Proxy instead. Details for completing and submitting the Form of Proxy are contained in the Notice of AGM which is on the Company's website (www.microsaic.com/investors/documents).
Enquiries: | |
Microsaic Systems plc Glenn Tracey, CEO - Bevan Metcalf, FD | +44 (0)1483 751 577 |
N+1 Singer (Nominated Adviser & Joint Broker) | +44 (0)20 7496 3000 |
Aubrey Powell / George Tzimas (Corporate Finance) | |
Tom Salvesen (Corporate Broking) | |
Turner Pope Investments (TPI) Limited (Broker) Andy Thacker / Zoe Alexander | +44 (0) 20 3657 0050 |
About Microsaic (www.microsaic.com)
Microsaic listed on AIM in 2011 to develop and commercialise micro-engineering chip-based mass spectrometry equipment. Having invested £30m over the last 20 years before and after the IPO, Microsaic has a robust patent portfolio in cutting-edge technology purpose built for "Industry 4.0" which enables analytical detection and characterisation at the point-of-need, whether within a human health environment, conventional laboratory setting, or within a bioprocessing facility for continuous mass spectrometer detection and monitoring of data at any step in the process workflow.
Microsaic's products and systems are commercially available through global markets via a network of regional and local partners, targeting its core laboratory, manufacturing and point-of-need applications.